Bibliography
- Borras-Blasco J, Gracia-Perez A, Rosique-Robles JD, Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen. Expert Opin Biol Ther 2010;10(3):301-7
- Kivitz A, Segurado OG. HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab. Expert Rev Med Devices 2007;4(2):109-16. Review
- Sanchez-Eslava L, Corominas H, Riera M, Figuls R. Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases. Reumatol Clin 2011;7(5):349-50
- Kivitz A, Cohen S, Dowd JE, Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther 2006;28(10):1619-29
- Royal College of Nursing. Assessing, managing and monitoring biologic therapies for inflammatory arthritis: guidance for rheumatology practitioners. 2009, London. Available from: www.rcn.org.uk
- Hunter J. Subcutaneous injection technique. Nurs Stand 2008;22(21):42-4